tradingkey.logo

ICU Medical Inc

ICUI
查看详细走势图
154.160USD
+4.520+3.02%
收盘 02/06, 16:00美东报价延迟15分钟
3.81B总市值
亏损市盈率 TTM

ICU Medical Inc

154.160
+4.520+3.02%
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

+3.02%

5天

+2.84%

1月

+2.55%

6月

+18.67%

今年开始到现在

+8.05%

1年

-1.59%

查看详细走势图

TradingKey ICU Medical Inc股票评分

单位: USD 更新时间: 2026-02-06

操作建议

ICU Medical Inc当前公司基本面数据相对健康,最新ESG披露属于行业领先水平。增长潜力很大。当前估值合理,在医疗设备与耗材行业排名39/205位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价181.40。中期看,股价处于上升通道。近一个月,市场表现一般,但公司基本面和技术面得分较高。目前股价在压力位和支撑位之间,可以做区间波段操作。

ICU Medical Inc评分

相关信息

行业排名
39 / 205
全市场排名
127 / 4521
所属行业
医疗设备与耗材

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

公司舆情

过去24小时
热度

过冷
过热
中性

ICU Medical Inc亮点

亮点风险
ICU Medical, Inc. develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications. Its product portfolio includes ambulatory, syringe, and large volume IV pumps and safety software; dedicated and non-dedicated IV sets, needlefree IV connectors, peripheral IV catheters, and sterile IV solutions; closed system transfer devices and pharmacy compounding systems; as well as a range of respiratory, anesthesia, patient monitoring, and temperature management products. Its Infusion Therapy products include Clave needlefree products, Neutron, ClearGuard, and Tego. Its oncology products include ChemoLock Closed System Transfer Devices (CSTD) and Deltec GRIPPER non-coring needles for portal access. Its vascular access products include Safe-T Wing venipuncture and blood collection devices; Port-A-Cath implantable port, and Portex arterial blood sampling syringes. Its Tracheostomy products include Portex BLUselect PVC tracheostomy tubes.
利润高增长
公司净利润处于行业前列,最新年度总收入2.38B美元
估值低估
公司最新PE估值-509.11,处于3年历史低位
机构加仓
最新机构持股29.13M股,环比增加6.47%
乔尔·格林布拉特持仓
明星投资者乔尔·格林布拉特持仓,最新持仓市值41.04K
活跃度增加
近期活跃度增加,过去20天平均换手率0.36

分析师目标

根据 6 位分析师
买入
评级
181.400
目标均价
+20.95%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议

ICU Medical Inc新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

ICU Medical Inc简介

ICU Medical, Inc. develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications. Its product portfolio includes ambulatory, syringe, and large volume IV pumps and safety software; dedicated and non-dedicated IV sets, needlefree IV connectors, peripheral IV catheters, and sterile IV solutions; closed system transfer devices and pharmacy compounding systems; as well as a range of respiratory, anesthesia, patient monitoring, and temperature management products. Its Infusion Therapy products include Clave needlefree products, Neutron, ClearGuard, and Tego. Its oncology products include ChemoLock Closed System Transfer Devices (CSTD) and Deltec GRIPPER non-coring needles for portal access. Its vascular access products include Safe-T Wing venipuncture and blood collection devices; Port-A-Cath implantable port, and Portex arterial blood sampling syringes. Its Tracheostomy products include Portex BLUselect PVC tracheostomy tubes.
公司代码ICUI
公司ICU Medical Inc
CEOJain (Vivek)
网址https://www.icumed.com/
KeyAI